Melanoma up to 2.5 times likelier to strike transplant, lymphoma patients

October 3, 2012

Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found. That is because their immune systems tend to be significantly depressed, making early detection of melanoma even more important, says co-author Jerry Brewer, M.D., a Mayo dermatologist. The findings are published in the October issue of Mayo Clinic Proceedings.

Melanoma strikes roughly 1 in 50 people in the general population, Dr. Brewer says. The odds of getting melanoma are up to 2.5 times higher in people who have received a transplant or who have lymphoma, and melanoma also is likelier to be fatal in those patients, he adds. Patients who have the form of lymphoma called and develop melanoma are 2.8 times more likely to die from metastatic melanoma, in which the cancer has spread from the skin to other parts of the body, such as .

The take-home message, Dr. Brewer says: If melanoma is found earlier in such patients, they will likely have better chances of survival. Melanoma can develop anywhere on the body. The first signs are often a change in a mole's appearance or the development of a new pigmented or unusual-looking growth.

"How you catch melanoma earlier is to be very aware of your skin," Dr. Brewer says. "These patients with immunosuppression should be looking themselves over head-to-toe once a month, they should be seeing a dermatologist once or twice a year, and if they have a lot of other risk factors, maybe more often than that."

Dr. Brewer also advises using sunscreen, trying to avoid the sun and steering clear of . The melanoma risk is so high in immunosuppressed patients that they should use sunscreen not only every day, but "almost as often as you brush your teeth," he says.

Explore further: Study finds dramatic rise in skin cancer in young adults

Related Stories

Study finds dramatic rise in skin cancer in young adults

April 2, 2012
Even as the rates of some cancers are falling, Mayo Clinic is seeing an alarming trend: the dramatic rise of skin cancer, especially among people under 40. According to a study by Mayo Clinic researchers published in the ...

What you need to know about sunburns and tanning

May 10, 2012
(AP) -- Roughly half of young adults under 30 say they've had a sunburn in the past year. Not a big deal?

Melanoma risk declines with self-exams plus doctor visit

August 24, 2012
(HealthDay)—Risk of deeper melanomas is reduced with self-examination of the skin one to 11 times a year, according to a study published online Aug. 16 in the British Journal of Dermatology.

Melanoma screening by physicians associated with finding more cancers than patient self-detection

July 18, 2011
Physician-based screening for melanoma is associated with higher rates of physician-detected melanoma and detection of thinner melanoma, according to a report published Online First today by Archives of Dermatology, one of ...

People with Parkinson's disease may have double the risk for melanoma

June 6, 2011
An analysis of several studies shows that people with Parkinson's disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.